Patients and Providers Index to Drug-Specific Information Index to Drug-Specific Information Postmarket Drug Safety Information for Patients andIndex to Drug-Specific Information | FDA Skip to main content Skip to

Science and Research Special Topics | FDA Skip to main content Skip to

& Johnson Consumer Inc. Issues Voluntary Recall of Specific NEUTROGENA® and AVEENO® Aerosol Sunscreen Products Due to

to develop generic drug products therapeutically equivalent to specific reference listed drugs. Increased transparency on product-specific guidances gives applicants seeking to develop generic drugsProduct-Specific Guidances for Generic Drug Development | FDA Skip to

Labeling Requirements for Specific Devices | FDA Skip to main content Skip to

Codes for Human Prescription Drug Labeling Generic Drugs - Specific Labeling Resources Biological Products - Specific Labeling Resources Frequently Asked Questions about Labeling for PrescriptionBiological Products - Specific Labeling Resources | FDA Skip to main content Skip

Codes for Human Prescription Drug Labeling Generic Drugs - Specific Labeling Resources Biological Products - Specific Labeling Resources Frequently Asked Questions about Labeling for PrescriptionGeneric Drugs - Specific Labeling Resources | FDA Skip to main content Skip

National Infrastructure Protection Program Sector-Specific Plans | FDA Skip to main content Skip to

and Biologics Animal and Veterinary Cosmetics Tobacco Products Topics About FDA Combination Products Regulatory Information Safety Emergency Preparedness InternationalSpecific Test Categories or Technologies: Laboratory Developed Tests FAQs | FDA Skip

Links to Center-Specific Submission Preparation Guidelines | FDA Skip to main content

Alerts: Specific Method/Preparation Recommendations Private Laboratory Testing Import Alerts: Specific Method/Preparation Recommendations Share Post Linkedin Email Print This pageImport Alerts: Specific Method/Preparation Recommendations | FDA Skip to main content

Biocompatibility Testing of Medical Devices - Standards Specific Information for the Accreditation Scheme for

Individual Product Bioequivalence Recommendations for Specific Products | FDA Skip to main content Skip to

Mouse Monoclonal Antibodies Specific to Trypanosoma Cruzi Antigens | FDA Skip to

Upcoming Product-Specific Guidances for Generic Drug Product Development | FDA Skip

Product-Specific Guidance Meetings Between FDA and ANDA Applicants Under

Frequently requested or proactively posted drug-specific and other records | FDA Skip to main

Biocompatibility Testing of Medical Devices - Standards Specific Information for the Accreditation Scheme for

Product-Specific Guidance Meetings Between FDA and ANDA Applicants Under

PSGs Updates on PSG Program AGENDA FDA RESOURCES FDA Product-Specific Guidances Upcoming Product-Specific Guidances for Generic Drug Product Development Product-SpecificFacilitating Generic Drug Product Development through Product-Specific Guidances - 04/25/2024 | FDA Skip to main

this canine guidance is: (1) to be more specific for certain specific canine issues not discussed in GFI #90/VICHCVM GFI #111 (VICH GL19) Effectiveness of Anthelmintics: Specific Recommendations for Canines | FDA Skip to main

this feline guidance is: (1) to be more specific for certain specific feline issues not discussed in GFI #90/VICHCVM GFI #113 (VICH GL20) Effectiveness of Anthelmintics: Specific Recommendations for Felines | FDA Skip to main

the equine guidance is: (1) to be more specific for certain specific equine issues not discussed in GFI #90/VICHCVM GFI #109 (VICH GL15) Effectiveness of Anthelmintics: Specific Recommendations for Equines | FDA Skip to main

the porcine guidance is: (1) to be more specific for certain specific porcine issues not discussed in GFI #90/VICHCVM GFI #110 (VICH GL16) Effectiveness of Anthelmintics: Specific Recommendations for Porcines | FDA Skip to main

the caprine guidance is: (1) to be more specific for certain specific caprine issues not discussed in the overallCVM GFI #97 (VICH GL14) Effectiveness of Anthelmintics: Specific Recommendations for Caprines | FDA Skip to main

the ovine guidance is: (1) to be more specific for certain specific ovine issues not discussed in the overallCVM GFI #96 (VICH GL13) Effectiveness of Anthelmintics: Specific Recommendations for Ovines | FDA Skip to main

the bovine guidance is: (1) to be more specific for certain specific bovine issues not discussed in the overallCVM GFI #95 (VICH GL12) Effectiveness of Anthelmintics: Specific Recommendations for Bovines | FDA Skip to main

for chickens is: (1) to be more specific for certain specific issues for chickens not discussed in GFICVM GFI #114 (VICH GL21) Effectiveness of Anthelmintics: Specific Recommendations for Chickens Gallus gallus | FDA Skip to

CVM GFI #276 Effectiveness of Anthelmintics: Specific Recommendations for Products Proposed for the

FDA In Brief: FDA Reminds Industry of Specific Regulations for the Use of Fluorinated

a small business owner, where can I find information specific for me? (Drugs) | FDA Skip to main

Due to Formaldehyde Emissions Found in Specific Conditions When Used with CARESCAPE R860, Engstrom Carestation or Pro

Commodity Specific Food Safety Guidelines for the Production, Harvest

Commodity Specific Food Safety Guidelines for the Fresh Tomato

Commodity Specific Food Safety Guidelines for the Lettuce and

the equine guidance is: (1) to be more specific for certain specific equine issues not discussed in GFI #90/VICHCVM GFI #109 (VICH GL15) Effectiveness of Anthelmintics: Specific Recommendations for Equines | FDA Skip to main

the caprine guidance is: (1) to be more specific for certain specific caprine issues not discussed in the overallCVM GFI #97 (VICH GL14) Effectiveness of Anthelmintics: Specific Recommendations for Caprines | FDA Skip to main

the ovine guidance is: (1) to be more specific for certain specific ovine issues not discussed in the overallCVM GFI #96 (VICH GL13) Effectiveness of Anthelmintics: Specific Recommendations for Ovines | FDA Skip to main

this feline guidance is: (1) to be more specific for certain specific feline issues not discussed in GFI #90/VICHCVM GFI #113 (VICH GL20) Effectiveness of Anthelmintics: Specific Recommendations for Felines | FDA Skip to main

this canine guidance is: (1) to be more specific for certain specific canine issues not discussed in GFI #90/VICHCVM GFI #111 (VICH GL19) Effectiveness of Anthelmintics: Specific Recommendations for Canines | FDA Skip to main

for chickens is: (1) to be more specific for certain specific issues for chickens not discussed in GFICVM GFI #114 (VICH GL21) Effectiveness of Anthelmintics: Specific Recommendations for Chickens Gallus gallus | FDA Skip to

to develop generic drug products therapeutically equivalent to specific reference listed drugs. Increased transparency on product-specific guidances gives applicants seeking to develop generic drugsProduct-Specific Guidances for Generic Drug Development | FDA Skip to

to develop generic drug products therapeutically equivalent to specific reference listed drugs. Increased transparency on product-specific guidances gives applicants seeking to develop generic drugsProduct-Specific Guidances for Generic Drug Development | FDA Skip to

to develop generic drug products therapeutically equivalent to specific reference listed drugs. Increased transparency on product-specific guidances gives applicants seeking to develop generic drugsProduct-Specific Guidances for Generic Drug Development | FDA Skip to

Lists Regulations Under Development and Updates Priority Guidance Topics for Foods Program | FDA Skip to main

Focus Areas of Regulatory Science - Approach Cross-cutting Topics: Women’s Health Regulatory Science Research Cross-cutting Topics: Maternal Health Regulatory Science Research Cross-cutting Topics: Pediatric Health Regulatory Science Research Cross-cutting Topics: Oncology Regulatory Science Research Cross-cutting Topics: Rare Diseases Regulatory Science Research Cross-cutting Topics: One Health Initiative Lifecycle of FDA-Regulated Products

Focus Areas of Regulatory Science - Approach Cross-cutting Topics: Women’s Health Regulatory Science Research Cross-cutting Topics: Maternal Health Regulatory Science Research Cross-cutting Topics: Pediatric Health Regulatory Science Research Cross-cutting Topics: Oncology Regulatory Science Research Cross-cutting Topics: Rare Diseases Regulatory Science Research Cross-cutting Topics: One Health Initiative Lifecycle of FDA-Regulated Products

Evaluation of Sex-Specific Data in Medical Device Clinical Studies - Guidance for

P&G Issues Voluntary Recall of Specific Old Spice and Secret Aerosol Spray Antiperspirants and

Science and Research Special Topics | FDA Skip to main content Skip to

Science and Research Special Topics | FDA Skip to main content Skip to

Science and Research Special Topics | FDA Skip to main content Skip to

Science and Research Special Topics | FDA Skip to main content Skip to

Lists Regulations Under Development and Updates Priority Guidance Topics for Foods Program | FDA Skip to main

Approach to Safety Data Collection in Specific Late-Stage Pre-approval or Post-approval Clinical Trials | FDA

ICSR Multiple Entities and/or a Specific Lot Numbers of a Constituent Part of

Medication Health Fraud for Specific Diseases and Conditions | FDA Skip to main

and Biologics Animal and Veterinary Cosmetics Tobacco Products Topics About FDA Combination Products Regulatory Information Safety Emergency Preparedness International

and Cellular and Tissue-Based Products (HCT/P): Specific Requirements | FDA Skip to main content Skip to

Kwik Trip, Inc. Recalls Specific Fruit Cups and Trays Due to Potential

Integrative Proteogenomics for Elucidation of Tumor-specific Cell Surface Proteomes in Ultra-rare Cancers | FDA

FDA Product-Specific Guidances: Lighting the Development Pathway for Generic

& Johnson Consumer Inc. Issues Voluntary Recall of Specific NEUTROGENA® and AVEENO® Aerosol Sunscreen Products Due to

Index to Drug-Specific Information | FDA Skip to main content Skip to

Mechanism Framework to Develop Individualized Therapies that Target Specific Genetic Conditions with Known Biological Cause | FDA Skip to

For Industry Color Additives Color Additives in Specific Products Color Additives Color Additives in Specific Products Share Post Linkedin Email Print In CosmeticsColor Additives in Specific Products | FDA Skip to main content Skip to

Bayer Issues Voluntary Recall of Specific Lotrimin® and Tinactin® Spray Products Due to

P&G Issues Voluntary Recall of Specific Old Spice and Secret Aerosol Spray Antiperspirants and

and Biologics Animal and Veterinary Cosmetics Tobacco Products Topics About FDA Combination Products Regulatory Information Safety Emergency Preparedness International

and Biologics Animal and Veterinary Cosmetics Tobacco Products Topics About FDA Combination Products Regulatory Information Safety Emergency Preparedness International

and Biologics Animal and Veterinary Cosmetics Tobacco Products Topics About FDA Combination Products Regulatory Information Safety Emergency Preparedness InternationalSpecific Devices for Home Use | FDA Skip to

to develop generic drug products therapeutically equivalent to specific reference listed drugs. Increased transparency on product-specific guidances gives applicants seeking to develop generic drugsProduct-Specific Guidances for Generic Drug Development | FDA Skip to

Science and Research Special Topics | FDA Skip to main content Skip to

and Biologics Animal and Veterinary Cosmetics Tobacco Products Topics About FDA Combination Products Regulatory Information Safety Emergency Preparedness International

Condition-Specific Meeting Reports and Other Information Related to

Local Officials In this section : Women's Health Topics Women's Health Topics 5 Healthy Aging Tips for Women Women andand Biologics Animal and Veterinary Cosmetics Tobacco Products Topics About FDA Combination Products Regulatory Information Safety Emergency Preparedness International

for Tru Fru, LLC Issues Voluntary Recall of Specific Varieties of Tru Fru Freeze Dried Products Due

and Biologics Animal and Veterinary Cosmetics Tobacco Products Topics About FDA Combination Products Regulatory Information Safety Emergency Preparedness International

indications for use should name the specific group of therapeutic products, rather than specific products. This guidance expands on the policy statementIn vitro Companion Diagnostic Devices for a Specific Group of Oncology Therapeutic Products | FDA Skip to

of Use and Disposal of Specific Pilot™ COVID-19 At-Home Tests in the

across the nation as well as through exploring specific mammography topics. For your feedback or questions, we invite youand Biologics Animal and Veterinary Cosmetics Tobacco Products Topics About FDA Combination Products Regulatory Information Safety Emergency Preparedness International

and Biologics Animal and Veterinary Cosmetics Tobacco Products Topics About FDA Combination Products Regulatory Information Safety Emergency Preparedness International

General/Specific Intended Use - Guidance for Industry | FDA Skip to

and Biologics Animal and Veterinary Cosmetics Tobacco Products Topics About FDA Combination Products Regulatory Information Safety Emergency Preparedness International

and Biologics Animal and Veterinary Cosmetics Tobacco Products Topics About FDA Combination Products Regulatory Information Safety Emergency Preparedness International

Local Officials In this section : Women's Health Topics Women's Health Topics 5 Healthy Aging Tips for Women Women andand Biologics Animal and Veterinary Cosmetics Tobacco Products Topics About FDA Combination Products Regulatory Information Safety Emergency Preparedness International

Local Officials In this section : Women's Health Topics Women's Health Topics 5 Healthy Aging Tips for Women Women andand Biologics Animal and Veterinary Cosmetics Tobacco Products Topics About FDA Combination Products Regulatory Information Safety Emergency Preparedness International

and Biologics Animal and Veterinary Cosmetics Tobacco Products Topics About FDA Combination Products Regulatory Information Safety Emergency Preparedness International

Officials In this section : Conversations with Experts on Food Topics Conversations with Experts on Food Topics Home Food Resources for You (Food) Conversations withand Biologics Animal and Veterinary Cosmetics Tobacco Products Topics About FDA Combination Products Regulatory Information Safety Emergency Preparedness International

Officials In this section : Conversations with Experts on Food Topics Conversations with Experts on Food Topics Home Food Resources for You (Food) Conversations withand Biologics Animal and Veterinary Cosmetics Tobacco Products Topics About FDA Combination Products Regulatory Information Safety Emergency Preparedness International

and Biologics Animal and Veterinary Cosmetics Tobacco Products Topics About FDA Combination Products Regulatory Information Safety Emergency Preparedness International

and Biologics Animal and Veterinary Cosmetics Tobacco Products Topics About FDA Combination Products Regulatory Information Safety Emergency Preparedness International

and Biologics Animal and Veterinary Cosmetics Tobacco Products Topics About FDA Combination Products Regulatory Information Safety Emergency Preparedness International

Kempler Lauren-Jei McCarthy Chanapa Tantibanchachai Contacts for Specific Drug Topics Topic Media Contact Compliance and Drug Enforcement Actionsand Biologics Animal and Veterinary Cosmetics Tobacco Products Topics About FDA Combination Products Regulatory Information Safety Emergency Preparedness International

Kempler Lauren-Jei McCarthy Chanapa Tantibanchachai Contacts for Specific Drug Topics Topic Media Contact Compliance and Drug Enforcement Actionsand Biologics Animal and Veterinary Cosmetics Tobacco Products Topics About FDA Combination Products Regulatory Information Safety Emergency Preparedness International

Kempler Lauren-Jei McCarthy Chanapa Tantibanchachai Contacts for Specific Drug Topics Topic Media Contact Compliance and Drug Enforcement Actionsand Biologics Animal and Veterinary Cosmetics Tobacco Products Topics About FDA Combination Products Regulatory Information Safety Emergency Preparedness International

Kempler Lauren-Jei McCarthy Chanapa Tantibanchachai Contacts for Specific Drug Topics Topic Media Contact Compliance and Drug Enforcement Actionsand Biologics Animal and Veterinary Cosmetics Tobacco Products Topics About FDA Combination Products Regulatory Information Safety Emergency Preparedness International

Kempler Lauren-Jei McCarthy Chanapa Tantibanchachai Contacts for Specific Drug Topics Topic Media Contact Compliance and Drug Enforcement Actionsand Biologics Animal and Veterinary Cosmetics Tobacco Products Topics About FDA Combination Products Regulatory Information Safety Emergency Preparedness International

and Biologics Animal and Veterinary Cosmetics Tobacco Products Topics About FDA Combination Products Regulatory Information Safety Emergency Preparedness International

consider providing guidance and/or additional resources on specific topics, such as compliance with applicable labeling requirements, over theand Biologics Animal and Veterinary Cosmetics Tobacco Products Topics About FDA Combination Products Regulatory Information Safety Emergency Preparedness International